SGLT2 inhibitor therapy in patients with type-2 diabetes mellitus: is acute kidney injury a concern?

2020 ◽  
Vol 33 (5) ◽  
pp. 985-994 ◽  
Author(s):  
Megan Leila Baker ◽  
Mark Anthony Perazella
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Acute Kidney Injury ◽  
Type 2 Diabetes Mellitus ◽  
Sglt2 Inhibitor ◽  
Kidney Injury ◽  
Inhibitor Therapy

1127-P: Real-World Clinical Outcomes Associated with Canagliflozin 100mg and with Intensification of SGLT2 Inhibitor Therapy Switching to Canagliflozin 300mg in Patients with Type 2 Diabetes Mellitus: The Real-WECAN Study

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1127-P
Author(s):  
JUAN J. GORGOJO-MARTINEZ ◽  
MANUEL A. GARGALLO-FERNANDEZ ◽  
ALBA GALDON ◽  
TERESA ANTÓN-BRAVO ◽  
MIGUEL BRITO-SANFIEL ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Clinical Outcomes ◽  
Real World ◽  
Sglt2 Inhibitor ◽  
Inhibitor Therapy ◽  
The Real

scholarly journals A clinical study of bilateral non-obstructive acute pyelonephritis with acute kidney injury in patients of type 2 diabetes mellitus

2014 ◽  
Vol 25 (2) ◽  
pp. 338 ◽  
Author(s):  
Manjusha Yadla ◽  
Sriramnaveen Parvithina ◽  
KrishnaKishore Chennu ◽  
Sandeep Reddy ◽  
A. V. S. S. N. Sridhar ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Acute Kidney Injury ◽  
Type 2 Diabetes Mellitus ◽  
Clinical Study ◽  
Acute Pyelonephritis ◽  
Kidney Injury
Sign in / Sign up

Export Citation Format

Share Document